pargyline has been researched along with Carcinogenesis in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y | 1 |
| Zhao, Y | 1 |
| Wang, L | 2 |
| Bohrer, LR | 1 |
| Pan, Y | 1 |
| Huang, H | 1 |
1 other study available for pargyline and Carcinogenesis
| Article | Year |
|---|---|
LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
Topics: Animals; Camptothecin; Carcinogenesis; Cell Line, Tumor; Cellular Senescence; Chromatin; Demethylati | 2018 |